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Abstract
Purpose: This study aimed to: 1) describe the 4-item Early Activity Scale for Endurance (EASE) scores and
Six-Minute Walk Test (6MWT) distances of children with cerebral palsy (CP) by functional ability level,
sex, and age; and 2) examine the convergent validity of the EASE to the 6MWT. Methods: 708 children
with CP (18-months to 12-years), GMFCS Levels I-V, completed the EASE, and 376 of the study
participants, (3-12-years), GMFCS Levels I-III, also completed the 6MWT. Results: Children with CP
present with variations in EASE scores and 6MWT distances based on GMFCS level and, to a lesser
extent, age. The EASE and 6MWT demonstrate a statistically significant but low, positive correlation.
Conclusions: Understanding the relationship between these outcomes and GMFCS levels and age, assists
clinicians in establishing plans of care targeted at improving endurance for activity and functional
walking capacity for children with CP.

Background
Children with cerebral palsy (CP) typically present with lower levels of daily physical activity than
children who are typically developing.1,2 Physical activity is defined as, “any bodily movement produced
by skeletal muscles that requires energy expenditure.”3(p.126) For children with CP, impairments in muscle
tone, postural control, strength, range of motion, and coordination may contribute to low levels of
physical activity, poor endurance, and limitations in functional mobility.4 Specifically, reduced endurance
has been identified as a main factor in decline in walking ability as children with cerebral palsy age,6-8
and may impact a child’s ability to fully participate in home, school, and community activities.9 Because
of these trends, it is important for rehabilitation providers to assess endurance of children with CP, to
track changes over time, and attempt to mediate further functional decline. Clinicians rely on readily
available, easily administered measures to establish a baseline and measure change over time. The Early

Activity Scale for Endurance (EASE)10, 11 (4 and 10 item versions) and six-minute walk test (6MWT)12 are
designed for these purposes.
The 4-item EASE is a short, parent completed measure of perceived endurance for activity for
children. The four items are: 1) My child’s physical activity level is similar to other children his or her age,
2) My child has a high physical energy level and rarely needs to take rests when moving himself or
herself around during daily activities and play time, 3) My child does enough activity so that he or she is
breathing quickly or gets flushing in his or her face at least one time each day, and 4) My child spends a
lot of his or her play or free time doing activities that require lots of physical energy. Parents rate each
item on a scale from 1 (Never) to 5 (Always), with higher scores indicating greater endurance for activity.
The average score for the four items is used for analysis. Acceptable test-retest reliability (ICC = 0.95,
95% CI: 0.90-0.98) and validity of the 10-item EASE have been reported with young children with CP.10,13
Calculations from the same data for the 4-item EASE demonstrated acceptable but slightly lower testretest reliability (ICC = 0.75 (95% CI 0.54-0.87).11 The 4-item and the 10-item EASE have demonstrated a
moderate correlation with the 6MWT (r=0.52 (p < .05) and r=0.57 (P = .001), respectively)11 in a sample
of 28 children ages 3 to 6 years of age (14 children without CP and 14 children with CP). In our previous
work, confirmatory factor analysis indicated that the 4-item EASE captured the construct of endurance
for activity well (Comparative fit index=0.998; Tucker Lewis Index=0.993),11 thus we chose to use it in
this study to reduce the requested response burden on the parent. However, additional information on
the reliability and validity of the 4-item EASE for older children is needed.
The Six Minute Walk Test (6MWT)14 is a test of submaximal walking endurance that has been
used extensively in children and adults. The 6MWT has excellent test-retest reliability (ICC=0.98),2,15 and
reproduciblility (r=0.87; P=.007; intraclass correlation coefficient [ICC]=0.80) and valid (r=0.948; P<.001)
in children with CP.16It is often clinically used as a “capacity-based” measure (what child can do in an

optimized clinical environment) of walking activity. Fitzgerald and colleagues17 published 6MWT
reference values for children with spastic CP and children who were developing typically ages 4-17
years. They reported significant differences in children with CP classified in levels I-III on the Gross
Motor Function Classification System (GMFCS)18 as compared with children developing typically.
The purpose of this study was to describe the EASE and 6MWT scores of young and school-aged
children with CP by gross motor function classification level, sex, and age. We hypothesized that
endurance and functional walking capacity would be higher in children with higher gross motor function,
not differ by sex, and be higher in older children. We also examined the convergent validity of the EASE
to the 6MWT scores to examine how closely these two measures are related. The results should provide
evidence-based data to evaluate endurance and monitor change over time for children with CP.
Methods
This study was part of a multisite, prospective cohort study entitled ‘On Track: Monitoring
Development of Children with Cerebral Palsy and Gross Motor Delay,’ which aimed to develop
longitudinal developmental curves and reference percentiles for impairments, health conditions, and
participation variables for children with cerebral palsy. The full study protocol, reported elsewhere,19
was reviewed and approved by the Institutional Review Boards (IRB) at all participating institutions and
recruitment sites. All parents or guardians provided informed consent and children, as appropriate and
in compliance with the specific IRB, provided assent. EASE and 6MWT data from the first assessment are
analyzed and reported within this paper.
Participants
A convenience sample of 708 children with CP ages 18-months up to the 12th birthday at study
onset, GMFCS Levels I-V participated in completing the EASE in this study. A smaller cohort of 376 of the

study participants, ages 3 up to the child’s 12th birthday (mean = 82.0 months, SD = 26.9 months),
GMFCS Levels I (n=176), II (n=138), and III (n=62) also participated in the 6MWT. Children were recruited
from across Canada, including Ontario, Newfoundland, Manitoba, Alberta, and British Columbia, and
four regions within the United States, including areas in and around, Georgia, Oklahoma, Pennsylvania,
and Washington. Participating children had a diagnosis of CP by a physician or demonstrated delay in
gross motor development in addition to impairments in: muscle tone, righting and equilibrium reactions,
anticipatory postural movements of the head, trunk, or legs during movement, and active range of
motion during movements. Children were excluded if their parents were unable to speak and
understand English, French or Spanish. Demographic information of the children and their families is
included in Table 1.
Procedure
At the initial On Track assessment session, the therapist and parent determined the child’s
GMFCS level via a consensus process.20 The GMFCS is a five-point classification system used to describe
gross motor function ability in children with CP.18 Distinctions between levels of the GMFCS are based on
the need for assistive devices and caregiver assistance. Inter-rater reliability, content and construct
validity, 18 and stability21 of the GMFCS for use with children with CP has been supported in the
literature. Additionally, the excellent reliability (ICC = 0.94) between therapist and family report for the
GMFCS has also been established.22
Consensus on the GMFCS classification between the therapist and the parent was achieved
98.7% of the time. In most cases where disagreements occurred, the parent’s classification was used for
analysis, and formal rules existed to determine instances where the assessor’s classification should be
used instead.20 These rules included situations where the assessor had written a compelling description
of the child’s capability that was lower than the parent-assigned GMFCS level, report of the use of the

incorrect age band for the GMFCS leading to an inaccurate classification, or assessor report that the
parent was not ready to participate in a discussion of consensus regarding GMFCS levels.20
The parents of all participants (GMFCS levels I-V) completed the EASE either online or within a
parent booklet. The smaller cohort of 376 of the study participants also completed the 6MWT with
trained and reliable therapist assessors. Assessors included 90 licensed physical and occupational
therapists in the communities where the children resided. They participated in a training session prior to
collecting data. For the 6MWT, the child was permitted to wear orthoses, if regularly used, and to use an
assistive mobility device, selecting the device that allowed for the most sustained walking cadence or
was typically be used for long walks. Assessors were instructed to select a walking course either indoors
or outdoors on a large (about 100 feet), flat (no hills or bumps), hard terrain (asphalt, pavement) that
would not require the child to make a 180-degree turn. The starting line was marked prior to beginning
the 6MWT, to allow for re-measurement, if needed. Standardized instructions were then used to
describe the 6MWT to the child, encouraging the child to walk as far as he/she could in 6 minutes. The
distance walked was measured using a calibrated measuring wheel, and a stopwatch was used to keep
track of the allocated time. Assessors provided pre-established verbal encouragements to the child at
each minute to encourage the child to keep going and do his/ her best. Conversations with the child
were limited so as not to impact or slow the walking pace. Assessors recorded the total number of feet
walked in 6-minutes.
Data Analysis
Descriptive data for the EASE and 6MWT distances were computed for children grouped by
GMFCS level (I-V), by age (18-months to 3 years, 3 to 6 years, 6 to 9 years, and 9 to 11 years), and
between boys and girls. Parametric statistics were used as the data demonstrated normal distributions.
A two-way ANOVA examining GMFCS by age interactions was completed, showing interactions were not
significant. Therefore, one-way ANOVA with post hoc Tukey tests were used to compare EASE scores

and 6MWT distances among GMFCS levels and age groupings. Independent t-tests were used to
examine differences between boys and girls. Convergent validity of the EASE and 6MWT was assessed
using Pearson’s r correlations for children classified as GMFCS levels I-III as a group and then individually
by level.
Results
Descriptive statistics are presented in Table 2. Mean EASE scores differed based on children’s
GMFCS levels (p<.001) except between Levels II and III (p=.09). Higher EASE scores, representing greater
perceived endurance for activity, were reported for children with higher gross motor function. Children
aged 1.5- to 3-years and 3- to 6-years had significantly lower EASE scores than children 9- to 12-years
(p=.01 and p<.001, respectively). No differences were noted between the other age groupings. EASE
scores were not significantly different between boys and girls (p=.11). See Figure 1.
< Insert Figure 1 about here>
On the 6MWT, children in GMFCS levels I, II, and III on average walked 1259.3 feet (383.8
meters), 922.0 feet (281.0 meters), and 545.8 feet (166.4 meters), respectively. Significant differences in
distance walked were noted across all GMFCS levels I-III (p<.001). Differences in walking distance were
noted across some of the age groupings (p <.001). Children 3-6 years walked significantly less than
children 6-9 years (p<.001) and 9-11 years (p<.001). No differences were noted in walking distance
between children 6-9 and 9-11 years (p=.29). Distance walked did not differ between girls and boys
(p=0.43). (See Figure 2).
<Insert Figure 2 about here>
The EASE and 6MWT demonstrated a statistically significant but low, positive correlation (r=.30,
p<.001) across GMFCS levels I-III, indicating that the EASE and 6MWT appear to measure different

constructs. Correlations between the EASE and 6MWT by individual GMFCS levels demonstrated low,
non-significant correlations of r=.14 for GMFCS level I, r=.07 for GMFCS level II, and r=.02 for GMFCS
level III. (See Table 3)
<Insert Table 3 about here>
Discussion
Parent perceived endurance for activity, as measured by the EASE, differed across GMFCS levels
with higher EASE scores reported for children with higher gross motor function; however, parents of
children in GMFCS Levels II and III reported similar perceived endurance. This finding is consistent with
the results of initial construct validity testing on the original 10-item EASE completed by McCoy and
colleagues10 who also reported significant differences across GMFCS levels (p<.001), except between
levels II and III (p=.62) for young children with CP. This may suggest that children in GMFCS levels II and
III demonstrate similar endurance levels for activity, or that the EASE is not sensitive enough to detect
the variations in endurance for activity between these two levels. Younger children, under 6-years of
age, were reported to have higher endurance than children 9-12 years of age. This decrease in
endurance in older children with CP has been frequently noted in the literature.6-8 EASE scores were not
different between sexes, which is again consistent with the findings of McCoy and colleagues.10
Functional walking capacity, as measured by the 6MWT, increased based on children’s walking
ability, children classified in GMFCS level I (walks in all settings) walked a greater distance than children
classified in GMFCS level II (difficulty walking long distances) or level III (walks with hand held mobility
device). Children classified in GMFCS level II (difficulty walking long distances) walked a greater distance
than children in GMFCS level III (walks with hand held mobility device). This finding is consistent with
previous research that also reported significant differences across GMFCS levels,14, 16 and may represent
the increasing energy cost23 and physical demand associated with walking for children in levels II and III.

Our hypothesis that walking capacity would increase with age was partially supported. Younger
children in our sample (ages 3-6 years) walked significantly less distance than older children (ages 6-12
years). However, continued improvement in walking capacity was not noted between the two older
groups of children. This finding may reflect that younger children with CP are still developing and
refining their gross motor abilities, typically reaching their functional plateau by five years of age.24 As
expected, there was no difference by sex.
The mean 6MWT distances in this study (GMFCS level I: 1259.3 feet (383.8 meters), GMFCS level
II: 922.0 feet (281.0 meters), and GMFCS level III 545.8 feet (166.4 meters) are substantially lower than
what was previously reported for children with CP. Thompson and colleagues14 reported mean distances
of 486.6 meters, 312.9 meters, and 240.2 meters 4-18 year old children with CP in GMFCS levels I, II, and
III, respectively. Fitzgerald and colleagues17 reported mean distances of 439.57 meters, 386.74 meters,
and 305.28 meters for 4-17 year old children with CP in GMFCS levels I, II, and III, respectively. These
studies included children up to 17 or 18 years of age, which represents an older sample than examined
in this current study, and this may account for some of the variations noted in the distances walked. The
study walking distances may also have been impacted by the location of testing within the natural home
or clinic environment, as opposed to within a standardized testing track used for all participants.
Additional research investigating these differences with an older sample of children is needed.
Scores on the EASE and 6MWT demonstrated a significant but low correlation across GMFCS
level I-III and non-significant, low correlations when examining the GMFCS levels individually. This
suggests that the EASE and 6MWT appear to assess different specific constructs associated with
endurance for activity. The 6MWT is often used as a measure of functional walking capacity and may not
clearly assess endurance for activity for children using a variety of forms of mobility rather than just
walking. The EASE is a proxy measure for endurance for activity that is based on the parent’s perception

of the child’s endurance ability, which introduces some variability in the measurement. For children in
GMFCS levels I and II, the EASE may provide information related to general endurance for activity, but
does not specifically capture walking capacity. The EASE also includes elements of frequency and
intensity of a variety of physical activities, and may be a better measure for use with children at GMFCS
levels III-V. Use of both measures may be important for children in GMFCS level III.
Clinical Relevance
We recommend therapists consider the impact of GMFCS level and age on endurance and
functional walking capacity of children with CP and tailor intervention programs to specifically address
these impairments. We also recommend therapists consider the use of standardized measures such as
the EASE and 6MWT to assess and monitor endurance and functional walking capacity of children with
CP to assist with appropriate intervention planning. Because of low convergent validity, consideration of
the construct of interest is needed if choosing between the EASE and 6MWT for children with CP.
Careful attention to preventing a decline in endurance and walking capacity may allow for increased
participation in life activities for children with CP.
Limitations
Participants in this study were recruited as a sample of convenience, which presents a potential
limitation; however, the GMFCS distribution of the larger On Track study participants is comparable to
incidence data reported in the literature, supporting the applicability of the findings.26 Variations in the
location of the 6MWT, due to weather or family relocation, and testing within the natural environment
may have impacted the distance walked for some children. Additionally, this study investigated the
shorter 4-item EASE, as opposed to the 10-item EASE, which demonstrated moderate correlation to the
6MWT in our previous work.10 More research is needed to determine the reliability and validity of the
EASE in older children.

Conclusion
Children with CP present with variations in endurance and functional walking capacity based on
GMFCS level and, to a lesser extent, age. The EASE and 6MWT are standardized assessments measuring
two different constructs, endurance and walking capacity respectively, which provide clinicians with
information that contributes to a comprehensive assessment of a child’s functional abilities.
Understanding the relationship between these outcomes and GMFCS levels and age, assists clinicians
with setting goals and creating intervention programs targeted at improving endurance for activity and
functional walking capacity. Children with CP who have greater endurance are afforded more
opportunities for participation in the community. As therapists develop intervention programs, careful
attention to monitoring and preventing a decline in endurance and walking capacity may allow for
increased participation in life activities for children with CP.
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Figure 1. EASE Comparisons
EASE Score by GMFCS Level

EASE Score by Age Grouping

EASE Score by Sex

Figure 2. 6MWT Comparison
6MWT by GMFCS Level

6MWT Distance by Age Group

6MWT Distances by Sex

Table 1. Child and Parent Demographics

Child Gender
EASE (n = 707)
6MWT (n = 376)
Child GMFCS Level
EASE (n = 707)
6MWT (n = 376)

Child Distribution of
Involvement*
EASE (n = 707)
6MWT (n = 376)
Child race*

Male

Participants
EASE
6MWT
n=708 (%)
n=376 (%)
396 (56)
209 (56)

Female

312 (44)

167 (44)

I
II
III
IV
V
Monoplegia
Hemiplegia
Diplegia
Triplegia
Quadriplegia
American Indian/Alaska Native

227 (32)
161 (23)
80 (11)
129 (18)
111 (16)
8 (1)
198 (28)
184 (26)
39 (6)
278 (39)
15 (2)

176 (47)
138 (37)
62 (17)

4 (1)
159 (42)
139 (37)
23 (6)
51 (14)
8 (2)

EASE (n = 699)
6MWT (n = 368)

Child ethnicity*
EASE (n = 703)
6MWT (n = 372)

Parent respondent race*
EASE (n = 698)
6MWT (n=369)

Parent respondent ethnicity*
EASE (n = 701)
6MWT (n = 371)

Parent respondent age, years*
EASE (n=694)
6MWT (n = 367)
Parent respondent relationship
to child*
EASE (n = 704)
6MWT (n =373)
Parent respondent education*
EASE (n = 700)
6MWT (n = 370)

Family Income*
EASE (n = 594)
6MWT (n = 307)

Asian
Black/African American
White
Multi
Hispanic
Non-Hispanic

40 (6)
60 (8)
503 (72)
81 (12)
49 (7)
654 (93)

23 (6)
25 (6)
276 (74)
36 (10)
26 (7)
346 (92)

Aboriginal
Non-Aboriginal
American Indian/Alaska Native
Asian
Black/African American
White
Multi
Hispanic
Non-Hispanic

31 (4)
672 (96)
15 (2)
51 (7)
56 (8)
550 (79)
26 (4)
32 (5)
669 (95)

357 (95)
16 (4)
9 (2)
26 (7)
21 (6)
302 (80)
11 (3)
16 (4)
355 (94)

Aboriginal
Non-Aboriginal

20 (3)
681 (97)

10 (3)
361 (96)

37.8 (7.9)

38.6 (7.8)

628 (89)

330 (88)

Father

51 (7)

33 (9)

Other

25 (4)

10 (3)

High School or less

160 (23)

66 (18)

Community College / Associate’s
Degree

212 (30)

122 (32)

University

328 (47)

179 (48)

≥$75,000
$60,000 - $74,999
$45,000 - $59,999
$30,000 - $44,999
≤$30,000
Canada

306 (52)
78 (13)
50 (8)
58 (10)
102 (17)
347 (49)

170 (55)
40 (13)
23 (8)
24 (8)
50 (16)
192 (51)

361 (51)

184 (49)

Mean (SD)
Mother

Country
EASE (n=708)
United States
6MWT (n=373)
GMFCS= Gross Motor Function Classification System Level
CAD = Canadian Dollars
USD = United States Dollars

SD = standard deviation
* report based on the available information
Notes: ‘mother’ includes mother, adoptive mother, foster mother, or custodial mother; ‘father’ includes
father, adoptive father, or step father; ‘other’ includes grandparent, nursing supervisor, or aunt.

Table 2. Mean EASE Scores and 6MWT Distances and Pairwise Comparisons
EASE
GMFCS
Mean (SD)
Comparison
Level I
3.9 (.7)
Level II
(n=227)
Level III
Level IV
Level V
Level II
3.4 (.8)
Level III
(n=161)
Level IV
Level V
Level III
3.1 (.8)
Level IV
(n=80)
Level V
Level IV
2.7 (.9)
Level V
(n=129)
Level V
1.8 (.9)
(n=111)
Age
Mean (SD)
Comparison
18 months - 3 years
3.3 (1.1)
3-6 years
(n=131)
6-9 years
9-12 years
3-6 years
3.3 (1.0)
6-9 years
(n=216)
9-12 years
6-9 years
3.1 (1.0)
9-12 years
(n=246)
9-12 years
2.9 (1.0)
(n=115)
Sex
Mean (SD)
Comparison
Male
3.2 (1.1)
Female
(n=396)
Female
3.1 (1.1)
(n=312)
6MWT
GMFCS
Mean (SD) in feet
Comparison
Mean (SD) in meters
Level I
1259.3 (349.3)
Level II
(n=176)
383.8 (106.5)
Level III
Level II
922.0 (358.1)
Level III

p-value
< .001
< .001
< .001
< .001
.09
< .001
< .001
.01
< .001
< .001

p-value
.99
.33
.01
.11
.001
.17

p-value
.11

p-value
< .001
< .001
< .001

(n=138)
Level III
(n=62)
Age

281.0 (109.2)
545.8 (324.9)
166.4 (99.0)
Mean (SD) in feet
Mean (SD) in meters
852.9 (397.1)
260.0 (121.0)
1088.2 (423.6)
332.0 (129.1)
1174.4 (428.1)
358.0 (130.5)
Mean (SD) in feet
Mean (SD) in meters
1033.5 (437.3)
315.0 (133.3)
998.2 (430.8)
304.3 (131.3)

3-6 years
(n=141)
6-9 years
(n=157)
9-12 years
(n=78)
Sex
Male
(n=209)
Female
(n=167)

Comparison

p-value

6-9 years
9-12 years
9-12 years

< .001
< .001
.29

Comparison

p-value

Female

.43

Table 3. Correlations Between the 6MWT Distances and EASE Scores
GMFCS (n)
Pearson r
p-value
Level I (176)

.14

.06

Level II (138)

.07

.44

Level III (62)

.02

.88

Total

.30

P<.001*

* Indicates significance at p>.05 level

